Effect of vehicle and route of administration of letrozole on ovarian function in a bovine model

Abstract

The objective of this study was to determine the effects of vehicle and route of administration of letrozole on ovarian function in sexually mature beef heifers. On Day 3 (Day 0 = ovulation), heifers were assigned randomly to four treatment groups and given 1 mg kg–1 letrozole intravenously (iv, n = 10) or intramuscularly (im, n = 10) or given a placebo iv (control iv, n = 5) or im (control im, n = 5). The interwave interval was longer in heifers treated with letrozole im than in im and iv controls (11.7 ± 0.30 vs 9.5 ± 0.50 and 10 ± 0.43, respectively; P < 0.05). Corpus luteum diameter profiles and plasma progesterone concentrations were greater (P < 0.03 and P < 0.05, respectively) in heifers treated with letrozole im compared with control im. Plasma oestradiol concentrations were lower in both letrozole-treated groups compared with controls (P ≤ 0.03). Plasma LH concentrations tended to be elevated at the time of wave emergence in heifers treated with letrozole im compared with other groups (group-by-day interaction, P = 0.06) and plasma FSH concentrations tended to be greater (P < 0.09) in heifers treated with letrozole by either route compared with a single control group. We conclude that intramuscular administration of letrozole in oil is a feasible route and vehicle for the development of a letrozole-based treatment protocol for herd synchronisation in cattle.